IKENA ONCOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.3 USD | -0.76% |
|
-2.26% | -34.01% |
| Mar. 12 | Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 12 | North American Morning Briefing : Inflation Data -2- | DJ |
Chart calendar Ikena Oncology, Inc.
3f6f40e00fa13900b1a13f070b41e3cf.X_ePCNA9lqjw6SEGcHcK6DvpwzQvLIMLVVNFgteefv0.bK33XqJMw8m_hxFTQUc8kE-dq2ttdrNzIiUC9a6qBKgwgdtZ4lTe8paLSg~89c897def8fbc8bf5f5763a25c9577fa
Upcoming events on Ikena Oncology, Inc.
Past events on Ikena Oncology, Inc.
| 2024-04-16 02:00 pm | Stifel Virtual Targeted Oncology Days Conference |
| 2024-03-12 08:00 am | Q4 2023 Earnings Release |
| 2024-03-05 12:50 pm | TD Cowen Health Care Conference - Panel |
| 2023-11-29 11:00 am | Piper Sandler Healthcare Conference |
| 2023-11-14 | Jefferies London Healthcare Conference |
| 2023-11-14 01:50 pm | Stifel Healthcare Conference |
| 2023-11-09 07:00 am | Q3 2023 Earnings Release |
| 2023-10-11 09:00 am | Extraordinary Shareholders Meeting |
| 2023-09-12 | H.C. Wainwright Global Investment Conference |
| 2023-09-11 03:35 pm | Morgan Stanley Global Healthcare Conference |
| 2023-08-10 08:00 am | Q2 2023 Earnings Release |
| 2023-06-09 08:30 am | Annual General Meeting |
| 2023-06-08 12:30 pm | Jefferies Global Healthcare Conference |
| 2023-05-31 09:00 am | TD Cowen Oncology Innovation Summit |
| 2023-05-15 07:50 am | Q1 2023 Earnings Release |
| 2023-04-25 02:30 pm | Stifel Virtual Targeted Oncology Day |
| 2023-03-14 07:00 am | Q4 2022 Earnings Release |
| 2023-03-08 08:00 am | American Association for Cancer Research Special Conference |
| 2023-03-07 02:10 pm | Cowen Health Care Conference |
| 2023-03-07 01:00 pm | American Association for Cancer Research Special Conference - Abstract No. - IK-595 |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 31,0 15,6 99.12% | 15,6 30,1 -48.17% | 9,16 11,9 -22.84% | 7,00 |
|
EBITDA Million USD | Released Forecast Spread | -44,6 | -33,6 -56,5 40.51% | -70,2 -71,0 1.21% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -44,5 | -34,1 -55,2 38.16% | -70,9 -55,5 -27.79% | -75,4 -73,9 -1.99% | -79,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -34,1 -54,3 37.21% | -68,8 -53,7 -28.07% | -68,3 -68,2 -0.14% | -76,6 |
|
Net income Million USD | Released Forecast Spread | -44,3 | -34,1 -55,2 38.18% | -68,8 -58,2 -18.13% | -68,2 -68,0 -0.29% | -74,7 |
|
EPS USD | Released Forecast Spread | -16,0 | -1,22 -2,71 54.95% | -1,90 -1,62 -17.65% | -1,63 -1,66 1.81% | -1,55 |
| Announcement Date | 05/03/21 | 17/03/22 | 14/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,2 4,79 322.44% | 3,38 4,57 -25.93% | 0,38 3,87 -90.14% | 6,40 4,32 48.06% | 5,45 20,0 -72.7% | 5,31 4,62 15.12% | 2,00 3,08 -34.99% | 1,19 2,84 -58.25% | 0,66 2,44 -72.98% | 2,33 | 2,33 | 2,33 | 2,33 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 2,79 -18,3 115.27% | -17,0 -14,8 -14.62% | -21,0 -17,8 -17.84% | -17,9 -18,2 1.98% | -15,1 0,30 -5077.11% | -15,5 -17,8 12.79% | -18,5 -18,5 0.29% | -19,5 -18,9 -2.97% | -21,9 -19,0 -15.59% | -19,7 | -19,3 | -20,3 | -20,5 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,80 -16,1 117.38% | -16,8 -15,0 -12.44% | -20,5 -17,0 -20.34% | -17,3 -18,2 4.83% | -14,1 8,63 -263.33% | -14,2 -16,6 14.42% | -17,1 -18,1 5.49% | -17,3 -18,3 5.27% | -19,7 -17,6 -11.87% | -18,9 | -18,5 | -19,5 | -19,8 | |
|
Net income Million USD | Released Forecast Spread | 2,80 -17,8 115.7% | -16,8 -15,2 -10.71% | -20,5 -17,3 -18.26% | -17,3 -17,9 3.02% | -14,1 -0,33 -4116.49% | -14,2 -16,6 14.4% | -17,1 -18,1 5.49% | -17,3 -18,4 5.89% | -19,5 -17,8 -9.26% | -18,9 | -18,5 | -19,5 | -19,8 | -15,5 |
|
EPS USD | Released Forecast Spread | 0,24 -0,51 146.88% | -0,47 -0,42 -11.37% | -0,57 -0,49 -16.8% | -0,48 -0,49 2.83% | -0,39 -0,15 -168.97% | -0,39 -0,47 16.67% | -0,44 -0,47 7.17% | -0,40 -0,43 6.98% | -0,40 -0,43 6.54% | -0,41 | -0,39 | -0,39 | -0,39 | -0,32 |
| Announcement Date | 17/03/22 | 12/05/22 | 11/08/22 | 07/11/22 | 14/03/23 | 15/05/23 | 10/08/23 | 09/11/23 | 12/03/24 | - | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Ikena Oncology, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IKNA Stock
- Calendar Ikena Oncology, Inc.
